FIBROSpect® HCV
Use
The FIBROSpect® HCV test is designed to assess the severity of liver fibrosis in patients with Hepatitis C Virus (HCV). It helps clinicians evaluate and monitor liver health, potentially reducing the need for repeated biopsies.
Special Instructions
Noninvasive test that can be repeated safely. Provides easy-to-read results that assist in patient management and treatment decisions.
Limitations
While the test offers an alternative to repeated liver biopsies, it may not replace the biopsy in all clinical settings. Results should be interpreted in conjunction with other clinical findings.
Methodology
Immunoassay (Multiplex Protein Panel)
Biomarkers
Result Turnaround Time
7 days
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
2.0 mL
Minimum Volume
0.5 mL for Peds
Container
Serum Separator Tube or Red-Top Tube
Storage Instructions
Ambient or cold pack. Do not freeze.
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 7 days |
| Refrigerated | 30 days |